Indoco Remedies Limited (INDOCO.BO)
Indoco Remedies Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Mumbai, MA, IN. The stock last traded at $220.20, down 1.03% on the session, giving a market capitalisation of $20.23B. Its beta of 0.34 implies it has historically moved less than the broad market.
Indoco Remedies Limited, headquartered in Mumbai, India, is a diversified pharmaceutical company founded in 1945 (formerly Indo Continental Trading Company). The company specializes in the development, manufacturing, marketing, and global distribution of both active pharmaceutical ingredients (APIs) and a broad spectrum of finished drug formulations. Their extensive product portfolio addresses numerous medical fields, including oral care, digestive health, respiratory ailments, anti-infectives, nutritional supplements, ophthalmology, antifungal treatments, hormonal therapies, dermatology, urology, diabetes management, gynaecological solutions, lifestyle products, pain management, and cardiovascular medicines. Additionally, Indoco offers a diverse range of branded generic pharmaceuticals, such as analgesic tablets and topical preparations, antihypertensive medications, protein supplements, multivitamin tablets and syrups, various antibiotic forms (tablets, syrups, and injectables), oral rehydration powders, anti-haemorrhoidals, antacids, and antihistamines. Beyond its core pharmaceutical production, Indoco Remedies provides comprehensive analytical testing services. These include impurity profiling, particle size analysis, polymorphism and compatibility studies, heavy metal detection, extractables and leachables assessments, lyophilization investigations, reference and working standards development, forced degradation studies, and chromatographic method development and validation. The company also extends its expertise to a suite of engineering and project management services, encompassing architectural design, lighting, mechanical and utility engineering, project and construction management, electrical systems, control system integration, piping, structural design, data transfer systems, and process engineering solutions. Furthermore, Indoco is a key provider of contract research and manufacturing services (CRAMS). This includes custom synthesis of molecules and intermediates, advanced process chemistry research and development, designing and scaling up non-infringing processes, and developing and validating analytical methods, alongside comprehensive contract manufacturing capabilities.
Indoco Remedies Limited is most often compared with the following Healthcare names: